Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Effect of tenofovir disoproxil fumarate on risk of renal abnormality in HIV-1-infected children on antiretroviral therapy: a nested case-control study.

Judd A, Boyd KL, Stöhr W, Dunn D, Butler K, Lyall H, Sharland M, Shingadia D, Riordan A, Gibb DM.

AIDS. 2010 Feb 20;24(4):525-34. doi: 10.1097/QAD.0b013e3283333680.

PMID:
20139752
2.

Systematic review and meta-analysis: renal safety of tenofovir disoproxil fumarate in HIV-infected patients.

Cooper RD, Wiebe N, Smith N, Keiser P, Naicker S, Tonelli M.

Clin Infect Dis. 2010 Sep 1;51(5):496-505. doi: 10.1086/655681. Review.

3.

Pharmacogenetics of tenofovir treatment.

Rodriguez-Novoa S, Labarga P, Soriano V.

Pharmacogenomics. 2009 Oct;10(10):1675-85. doi: 10.2217/pgs.09.115. Review.

PMID:
19842939
4.

Review of tenofovir use in HIV-infected children.

Aurpibul L, Puthanakit T.

Pediatr Infect Dis J. 2015 Apr;34(4):383-91. doi: 10.1097/INF.0000000000000571. Review.

PMID:
25247583
5.

Tenofovir-associated nephrotoxicity in two HIV-infected adolescent males.

Wood SM, Shah SS, Steenhoff AP, Meyers KE, Kaplan BS, Rutstein RM.

AIDS Patient Care STDS. 2009 Jan;23(1):1-4. doi: 10.1089/apc.2008.0106. Review.

PMID:
19183077
7.

Tenofovir-induced nephrotoxicity: incidence, mechanism, risk factors, prognosis and proposed agents for prevention.

Jafari A, Khalili H, Dashti-Khavidaki S.

Eur J Clin Pharmacol. 2014 Sep;70(9):1029-40. doi: 10.1007/s00228-014-1712-z. Epub 2014 Jun 25. Review.

PMID:
24958564
8.

Tenofovir disoproxil fumarate in pregnancy and prevention of mother-to-child transmission of HIV-1: is it time to move on from zidovudine?

Foster C, Lyall H, Olmscheid B, Pearce G, Zhang S, Gibb DM.

HIV Med. 2009 Aug;10(7):397-406. doi: 10.1111/j.1468-1293.2009.00709.x. Epub 2009 May 12. Review.

9.

Safety of tenofovir during pregnancy for the mother and fetus: a systematic review.

Wang L, Kourtis AP, Ellington S, Legardy-Williams J, Bulterys M.

Clin Infect Dis. 2013 Dec;57(12):1773-81. doi: 10.1093/cid/cit601. Epub 2013 Sep 17. Review.

10.

Tenofovir effect on the kidneys of HIV-infected patients: a double-edged sword?

Tourret J, Deray G, Isnard-Bagnis C.

J Am Soc Nephrol. 2013 Oct;24(10):1519-27. doi: 10.1681/ASN.2012080857. Epub 2013 Sep 19. Review.

11.

Novel antiretroviral drugs and renal function monitoring of HIV patients.

Maggi P, Montinaro V, Mussini C, Di Biagio A, Bellagamba R, Bonfanti P, Calza L, Cherubini C, Corsi P, Gargiulo M, Montella F, Rusconi S.

AIDS Rev. 2014 Jul-Sep;16(3):144-51. Review.

PMID:
25102336
12.

Renal toxicity associated with antiretroviral therapy.

Calza L.

HIV Clin Trials. 2012 Jul-Aug;13(4):189-211. doi: 10.1310/hct1304-189. Review.

PMID:
22849961
13.

Chronic Kidney Disease and Antiretroviral Therapy in HIV-Positive Individuals: Recent Developments.

Achhra AC, Nugent M, Mocroft A, Ryom L, Wyatt CM.

Curr HIV/AIDS Rep. 2016 Jun;13(3):149-57. doi: 10.1007/s11904-016-0315-y. Review.

PMID:
27130284
14.

Proteinuria in paediatric patients with human immunodeficiency virus infection.

Giacomet V, Erba P, Di Nello F, Coletto S, Viganò A, Zuccotti G.

World J Clin Cases. 2013 Apr 16;1(1):13-8. doi: 10.12998/wjcc.v1.i1.13. Review.

15.

Antiretroviral therapy, immune suppression and renal impairment in HIV-positive persons.

Ryom L, Mocroft A, Lundgren JD.

Curr Opin HIV AIDS. 2014 Jan;9(1):41-7. doi: 10.1097/COH.0000000000000023. Review.

PMID:
24225381
Items per page

Supplemental Content

Write to the Help Desk